IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors

Sarah Cannon Research Institute, Nashville

James Graham Brown Cancer Center, Louisville

Park Nicollet Frauenshuh Cancer Center, Saint Louis Park

Centre Leon Berard, Lyon

NEXT Oncology, San Antonio

ICAHN School of Medicine at Mount Sinai, New York

Centre Georges-Francois Leclerc, Dijon

Hôpital de la Timone- AP-HM, Marseille

Institut du Cancer de Montpellier, Montpellier

Centre Hospitalier Universitaire- Hôpital Nord Laennec, Nantes

Centre Eugène Marquis, Rennes

Institut Gustave Roussy, Villejuif